Basma Adeem Medical company (TADAWUL:9626)
Saudi Arabia
· Delayed Price · Currency is SAR
5.75
0.00 (0.00%)
Apr 29, 2026, 2:53 PM AST
TADAWUL:9626 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | 7.3 | 6.3 | 4.87 | 3.78 |
| Depreciation & Amortization | 2.71 | 1.25 | 1.17 | 0.77 |
| Loss (Gain) From Sale of Assets | -0.04 | - | - | - |
| Other Operating Activities | 1.31 | 0.74 | 0.34 | 0.28 |
| Change in Accounts Receivable | - | - | - | -0.08 |
| Change in Inventory | 0.01 | -0.59 | -0.47 | -0.12 |
| Change in Accounts Payable | 0.63 | -0.09 | -0.43 | 2.41 |
| Change in Other Net Operating Assets | -0.57 | 0.37 | -0.27 | - |
| Operating Cash Flow | 11.37 | 7.98 | 5.21 | 7.04 |
| Operating Cash Flow Growth | 42.49% | 53.17% | -26.01% | - |
| Capital Expenditures | -6.61 | -1.32 | -1.14 | -1.8 |
| Sale of Property, Plant & Equipment | 0.05 | - | - | - |
| Investing Cash Flow | -6.56 | -1.32 | -1.14 | -1.8 |
| Long-Term Debt Repaid | -2.04 | -1.23 | -1.11 | -0.63 |
| Net Debt Issued (Repaid) | -2.04 | -1.23 | -1.11 | -0.63 |
| Issuance of Common Stock | 16.53 | 6.5 | - | - |
| Common Dividends Paid | - | - | - | -3.6 |
| Financing Cash Flow | 14.5 | 5.27 | -1.11 | -4.23 |
| Net Cash Flow | 19.3 | 11.93 | 2.96 | 1.01 |
| Free Cash Flow | 4.76 | 6.66 | 4.07 | 5.24 |
| Free Cash Flow Growth | -28.52% | 63.68% | -22.33% | - |
| Free Cash Flow Margin | 10.47% | 19.64% | 15.34% | 23.90% |
| Free Cash Flow Per Share | 0.26 | 0.58 | 0.43 | - |
| Levered Free Cash Flow | 1.19 | 4.1 | 2.21 | - |
| Unlevered Free Cash Flow | 1.66 | 4.31 | 2.44 | - |
| Change in Working Capital | 0.08 | -0.31 | -1.17 | 2.2 |
Source: S&P Capital IQ. Standard template.
Financial Sources.